Iminostilbene, also known as 5H-dibenzo[b,f]azepine, is a dibenzazepine derivative and a key intermediate or related impurity found in the synthesis and degradation of anticonvulsant and mood-stabilizing… Read more
![Chemical structure of 1-(10,11-Dibromo-4aH-dibenzo[b,f]azepin-5(11aH)-yl)ethanone](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1-1011-Dibromo-4aH-dibenzobfazepin-511aH-ylethanone.png&w=3840&q=75)
![Chemical structure of 10,11-Dibromo-11,11a-dihydro-4aH-dibenzo[b,f]azepin-5(10H)-yl Acetate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1011-Dibromo-1111a-dihydro-4aH-dibenzobfazepin-510H-yl-Acetate.png&w=3840&q=75)
![Chemical structure of 10-Bromo-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carbonyl Bromide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2512216-68-9-10-Bromo-1011-dihydro-5H-dibenzobfazepine-5-carbonyl-Bromide.png&w=3840&q=75)


![Chemical structure of 5-methyl-5H-dibenzo[b,f]azepine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F52249-32-8-5-methyl-5H-dibenzobfazepine.png&w=3840&q=75)
![Chemical structure of 5-Nitroso-5H-dibenzo[b,f]azepine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F38652-29-8-5-Nitroso-5H-dibenzobfazepine.png&w=3840&q=75)











Iminostilbene, also known as 5H-dibenzo[b,f]azepine, is a dibenzazepine derivative and a key intermediate or related impurity found in the synthesis and degradation of anticonvulsant and mood-stabilizing pharmaceuticals such as carbamazepine. Laboratories utilize this comprehensive range of Iminostilbene reference standards, which encompasses structural analogues, nitroso variants, dihydrodiol metabolites, and brominated impurities, to conduct rigorous impurity profiling and method validation. By comparing test samples against these high-quality standards, analytical chemists can identify and quantify trace contaminants within pharmaceutical formulations. The inclusion of stable isotope labelled compounds, such as deuterated derivatives, is essential for accurate quantification during mass spectrometry analysis. These materials support essential quality control processes, ensuring that final drug products meet regulatory specifications for safety and composition while minimizing the presence of degradation products or synthetic by-products throughout the development lifecycle.